Filing Flows › Usana Health Sciences (USNA) › Gross margin
Usana Health Sciences (USNA) gross margin by quarter
Usana Health Sciences' gross margin was 76.2% in Q1 2026 (first quarter 2026), -2.5 pts from Q2 2025. Over the last 4 quarters it ranged from 76.2% (Q1 2026) to 82.0% (Q4 2024).
| Quarter | Gross margin | Q/Q | Y/Y |
|---|---|---|---|
| Q1 2026 | 76.2% | -2.5 pts | -2.7 pts |
| Q2 2025 | 78.7% | -0.3 pts | — |
| Q1 2025 | 79.0% | -3.0 pts | — |
| Q4 2024 | 82.0% | — | — |
Q1 2026 at a glance
Usana Health Sciences, Q1 2026: revenue $250M (+0.3% year over year), operating margin 5.5%, net earnings $7.5M, operating cash flow $9.8M. The chart follows the revenue to costs, profit and cash.
Questions
What is Usana Health Sciences' gross margin?
Usana Health Sciences' gross margin was 76.2% in Q1 2026 (first quarter 2026), -2.5 pts from Q2 2025.
How has Usana Health Sciences' gross margin changed?
Over the last 4 quarters it ranged from 76.2% (Q1 2026) to 82.0% (Q4 2024).